首页|原发性肝癌患者血清CXCLs、MMPs及外周血炎性反应指标与治疗后短期预后的相关性

原发性肝癌患者血清CXCLs、MMPs及外周血炎性反应指标与治疗后短期预后的相关性

Correlation between serum CXCLs,MMPs and inflammatory markers in peripheral blood of patients with primary liver cancer and short-term prognosis after treatment

扫码查看
目的 探究原发性肝癌患者血清CXC趋化因子配体(CXCLs)、基质金属蛋白酶(MMPs)及外周血炎性反应指标与治疗后短期预后的相关性.方法 选取2021年9月—2023年9月首都医科大学附属北京佑安医院普外中心收治的原发性肝癌患者117例为研究对象,根据患者治疗后3个月预后情况分为短期预后不良组(n=27)和短期预后良好组(n=90).检测患者血清 CXCLs(CXCL2、CXCL8、CXCL9、CXCL13)、MMPs(MMP-2、MMP-7、MMP-9、MMP-14)水平及外周血炎性反应指标[中性粒细胞/淋巴细胞比值(NLR)、淋巴细胞/单核细胞比值(LMR)、系统免疫炎性指数(SII)];Spearman相关性分析差异性指标与原发性肝癌患者治疗后短期预后不良的相关性;多因素Logistic回归分析原发性肝癌患者治疗后短期预后不良的影响因素.结果 短期预后不良组血清CXCL8、CXCL9、CXCL13水平均高于短期预后良好组(t/P=3.876/<0.001、4.779/<0.001、5.434/<0.001);短期预后不良组血清MMP-2、MMP-7、MMP-9、MMP-14 水平均高于短期预后良好组(t/P=6.775/<0.001、5.376/<0.001、6.377/<0.001、6.565/<0.001);短期预后不良组SII高于短期预后良好组(t/P=5.569/<0.001);Spearman相关性分析表明,原发性肝癌患者肿瘤长径、多发肿瘤、合并肝硬化、CXCL8、CXCL9、CXCL13、MMP-2、MMP-7、MMP-9、MMP-14、SII与治疗后短期预后不良均呈正相关(r=0.286、0.209、0.200、0.415、0.417、0.420、0.459、0.383、0.493、0.442、0.440,P 均<0.05);多因素Logistic回归分析结果显示,血清CXCL8、CXCL9、CXCL13、MMP-2、MMP-7、MMP-9、MMP-14水平及SII升高是原发性肝癌患者治疗后短期预后不良的独立危险因素[OR(95%CI)=1.021(1.009~1.063)、1.043(1.006~1.082)、1.087(1.011~1.170)、1.455(1.045~2.026)、1.096(1.001~1.201)、1.027(1.011~1.074)、1.128(1.083~1.295)、1.044(1.024~1.066)].结论 血清CXCLs、MMPs水平及SII高的原发性肝癌患者治疗后短期预后往往较差,密切监测血清CXCLs、MMPs水平及SII变化对于准确评估原发性肝癌患者预后具有一定临床意义.
Objective To explore the correlation between serum C-X-C chemokine ligand(CXCLs),matrix metallo-proteinase(MMPs),peripheral blood inflammation and short-term prognosis in patients with primary liver cancer.Methods One hundred and seventeen patients diagnosed with primary liver cancer at our hospital between September 2021 and September 2023 were categorized into two cohorts based on their short-term prognosis:a cohort with optimistic short-term prognosis(n=90)and a cohort with unfavorable short-term prognosis(n=27)within 3 months post-treatment.Various pa-rameters including general clinical characteristics,levels of CXCLs(CXCL2,CXCL8,CXCL9,CXCL13),levels of MMPs(MMP-2,MMP-7,MMP-9,MMP-14),and peripheral blood inflammatory markers[neutrophil/lymphocyte ratio(NLR),lym-phocyte/monocyte ratio(LMR),and systemic immune inflammation index(SII)]were measured and compared between these two groups.Spearman correlation analysis was used to analyze the correlation between differential indicators and poor short-term prognosis after treatment in patients with primary liver cancer;multivariate Logistic regression analysis was used to analyze the influencing factors of poor short-term prognosis after treatment in patients with primary liver cancer.Results The levels of serum CXCL8,CXCL9,and CXCL13 in the poor short-term prognosis group were higher than those in the good short-term prognosis group(t/P=3.876/<0.001,4.779/<0.001,5.434/<0.001);the levels of serum MMP-2,MMP-7,MMP-9,and MMP-14 in the poor short-term prognosis group were higher than those in the good short-term prognosis group(t/P=6.775/<0.001,5.376/<0.001,6.377/<0.001,6.565/<0.001);the SII in the poor short-term prognosis group was higher than that in the good short-term prognosis group(t/P=5.569/<0.001);Spearman correlation analysis showed that tumor diameter,multiple tumors,cirrhosis,CXCL8,CXCL9,CXCL13,MMP-2,MMP-7,MMP-9,MMP-14,and SII were posi-tively correlated with poor short-term prognosis after treatment in patients with primary liver cancer(r=0.286,0.209,0.200,0.415,0.417,0.420,0.459,0.383,0.493,0.442,0.440,all P<0.05);the results of multivariate Logistic regression analysis showed that high levels of serum CXCL8,CXCL9,CXCL13,MMP-2,MMP-7,MMP-9,MMP-14,and high SII were independent risk factors for poor short-term prognosis after treatment in patients with primary liver cancer[OR(95%CI)=1.021(1.009-1.063),1.043(1.006-1.082),1.087(1.011-1.170),1.455(1.045-2.026),1.096(1.001-1201),1.027(1.011-1.074),1.128(1.083-1.295),1.044(1.024-1.066)].Conclusion The short-term prognosis of patients with primary liver cancer with high levels of serum CXCLs,MMPs,and SII is often poor after treatment.Closely monitoring the changes in serum CXCLs,MMPs levels,and SII has certain clinical significance for accurately assessing the prognosis of patients with primary liver cancer.

Primary liver cancerChemokineMatrix metalloproteinasePeripheral blood inflammation indexSys-temic immune inflammatory indexPrognosis

邸亮、朱梓兆、郭庆良、赵晓飞、丁兢

展开 >

100069 北京,首都医科大学附属北京佑安医院普外中心

110006 沈阳,沈阳市第六人民医院普外一科

原发性肝癌 趋化因子 基质金属蛋白酶 炎性反应指标 系统免疫炎性指数 预后

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(11)